Icecure Medical Stock Forum

$Icecure Medical (ICCM.US)$
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
Tuesday, 4th February at 8:30 am
Two independent studies of ProSense® cryoablation in breast cancer were presented, one of which won the Highest Scoring Abstract Award in its category
Hands-on ProSense® training featured during the S...

$Icecure Medical (ICCM.US)$ Icecure Files for Regulatory Approval of Prosense® Cryoablation System in China

$Icecure Medical (ICCM.US)$
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
Monday, 27th January at 8:30 am
Seeks to expand regulatory approval in China where IceSense3 has already been approved
CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, t...

$Icecure Medical (ICCM.US)$
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
Monday, 13th January at 7:00 am
Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors.
FDA decision on market authorization of ProSense® for early-stage breast cancer is expected in the first quarter of 2025.
FDA Advisory Panel voted in favor of ProSense®'...

$Icecure Medical (ICCM.US)$ I am ready for something good

$Icecure Medical (ICCM.US)$ move on up for me

$Icecure Medical (ICCM.US)$
Patents and compliance regained....
this should be moving.   🤷

$Icecure Medical (ICCM.US)$
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
Monday, 6th January at 8:30 am
CAESAREA, Israel, Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a notification letter from Nasdaq Stock Market LLC...

$Icecure Medical (ICCM.US)$ IceCure Received Intention To Grant Notice From European Patent Office For "Cryogenic System Connector"
Benzinga· 1 min ago

$Icecure Medical (ICCM.US)$
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology
Friday, 3rd January at 8:30 am
XSense™ system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure
CAESAREA, Israel, Jan. 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasiv...